These VCAM-1-mediated interactions are involved in both inflammatory cell recruitment during inflammatory bowel disease (IBD) and cancer cell metastasis in colorectal cancer (CRC), highlighting the therapeutic potential of VCAM-1 as a drug target for both pathologies. The gene discussed is VCAM1; the disease is inflammatory bowel disease.